These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32246516)

  • 1. Efficacy and safety of adalimumab in difficult-to-treat psoriasis.
    Lanna C; Zangrilli A; Bavetta M; Campione E; Bianchi L
    Dermatol Ther; 2020 May; 33(3):e13374. PubMed ID: 32246516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab: A Review in Chronic Plaque Psoriasis.
    Burness CB; McKeage K
    Drugs; 2015 Dec; 75(18):2119-30. PubMed ID: 26586242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab-induced scalp psoriasis with severe alopecia.
    Özkur E; Altunay İK; Leblebici C; Topkarcı Z; Erdem Y
    Dermatol Ther; 2019 Sep; 32(5):e13033. PubMed ID: 31350777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.
    Foley P; Gordon K; Griffiths CEM; Wasfi Y; Randazzo B; Song M; Li S; Shen YK; Blauvelt A
    JAMA Dermatol; 2018 Jun; 154(6):676-683. PubMed ID: 29799960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis.
    Leonardi C; Papp K; Strober B; Thaçi D; Warren RB; Tyring S; Arikan D; Karunaratne M; Valdecantos WC
    Br J Dermatol; 2019 Jan; 180(1):76-85. PubMed ID: 30169904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles).
    Sánchez-Regaña M; Aldunce Soto MJ; Belinchón Romero I; Ribera Pibernat M; Lafuente-Urrez RF; Carrascosa Carrillo JM; Ferrándiz Foraster C; Puig Sanz L; Daudén Tello E; Vidal Sarró D; Ruiz-Villaverde R; Fonseca Capdevila E; Rodríguez Cerdeira MC; Alsina Gibert MM; Herrera Acosta E; Marrón Moya SE;
    Actas Dermosifiliogr; 2014 Dec; 105(10):923-34. PubMed ID: 24852726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice.
    Sola-Ortigosa J; Sánchez-Regaña M; Umbert-Millet P
    J Dermatolog Treat; 2012 Jun; 23(3):203-7. PubMed ID: 21787203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of psoriatic arthritis on the efficacy of adalimumab and on the treatment response of other markers of psoriasis burden: subanalysis of the BELIEVE study.
    Paul C; van de Kerkhof P; Puig L; Unnebrink K; Goldblum O; Thaçi D
    Eur J Dermatol; 2012; 22(6):762-9. PubMed ID: 23178916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation.
    Zangrilli A; Bavetta M; Bianchi L
    Expert Opin Drug Saf; 2020 Apr; 19(4):433-438. PubMed ID: 32250180
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab in Chronic Plaque Psoriasis: A Clinical Guide.
    Wu JJ; Valdecantos WC
    J Drugs Dermatol; 2017 Aug; 16(8):779-790. PubMed ID: 28809993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective study.
    Valenti M; Gargiulo L; Ibba L; Cortese A; Toso F; Orsini D; Lora V; Frascione P; Sena P; Carugno A; Assorgi C; Costanzo A; Narcisi A
    J Dermatol; 2024 Jun; 51(6):839-843. PubMed ID: 38292002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice.
    Khobzey K; Liskova I; Szegedi A; Pavlovsky L; Lunder T; Kingo K; Miljković J; Péč J; Bohinc M; Hojnik M
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):11-14. PubMed ID: 28352929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin advanced glycation end products as a diagnostic and monitoring tool among psoriatic patients: how the therapy helps reduce cardiovascular disease risk.
    Lanna C; Zangrilli A; Bavetta M; Diluvio L; Campione E; Bianchi L
    Int J Dermatol; 2022 May; 61(5):577-581. PubMed ID: 34432309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
    Revicki DA; Menter A; Feldman S; Kimel M; Harnam N; Willian MK
    Health Qual Life Outcomes; 2008 Oct; 6():75. PubMed ID: 18831744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma.
    Lanna C; Galluzzi C; Zangrilli A; Bavetta M; Bianchi L; Campione E
    J Dermatolog Treat; 2022 Feb; 33(1):531-534. PubMed ID: 32419527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab for treating childhood plaque psoriasis: a clinical trial evaluation.
    Di Lernia V
    Expert Opin Biol Ther; 2017 Dec; 17(12):1553-1556. PubMed ID: 28829204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis.
    Bongiorno MR; Pistone G; Doukaki S; Aricò M
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers.
    Orsini D; Gargiulo L; Ibba L; Cascio Ingurgio R; Valenti M; Perugini C; Pacifico A; Maramao FS; Frascione P; Costanzo A; Narcisi A
    J Dermatolog Treat; 2023 Dec; 34(1):2220849. PubMed ID: 37288760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.